Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Mar 5;93(5):2174–2179. doi: 10.1073/pnas.93.5.2174

Factor XII-induced mitogenesis is mediated via a distinct signal transduction pathway that activates a mitogen-activated protein kinase.

E M Gordon 1, N Venkatesan 1, R Salazar 1, H Tang 1, K Schmeidler-Sapiro 1, S Buckley 1, D Warburton 1, F L Hall 1
PMCID: PMC39930  PMID: 8700904

Abstract

Clotting factor XII (Hageman factor) contains epidermal growth factor (EGF)-homologous domains and is reported to be a potent mitogen for human hepatoma (HepG2) cells. In this study, we tested whether factor XII exhibits growth factor activity on several other EGF-sensitive target cells, including fetal hepatocytes, endothelial cells, alveolar type II cells, and aortic smooth muscle cells. We found that factor XII significantly enhanced [3H]thymidine incorporation in aortic smooth muscle cells (SMCs) and all other cells tested. Tyrphostin, a growth factor receptor/tyrosine kinase antagonist, inhibited both EGF- and factor XII-induced responses. However, differences in the levels of magnitude of DNA synthesis, the observed synergism between EGF and factor XII, and the differential sensitivity to tyrphostin suggest that the EGF receptor and the factor XII receptor may be nonidentical. The factor XII-induced mitogenic response was achieved at concentrations that were 1/10th the physiologic range for the circulating factor and was reduced by popcorn inhibitor, a specific factor XII protease inhibitor. Treatment of aortic SMCs with factor XII, as well as activated factor XII, resulted in a rapid and transient activation of a mitogen-activated/extracellular signal-regulated protein kinase with peak activity/tyrosine phosphorylation observed at 5 to 10 min of exposure. Taken together, these data (i) confirm that clotting factor XII functions as a mitogenic growth factor and (ii) demonstrate that factor XII activates a signal transduction pathway, which includes a mitogen-activated protein kinase.

Full text

PDF
2174

Images in this article

2178Fig. 3
on p.2178

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Astermark J., Stenflo J. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region. J Biol Chem. 1991 Feb 5;266(4):2438–2443. [PubMed] [Google Scholar]
  2. Bilder G. E., Krawiec J. A., McVety K., Gazit A., Gilon C., Lyall R., Zilberstein A., Levitzki A., Perrone M. H., Schreiber A. B. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am J Physiol. 1991 Apr;260(4 Pt 1):C721–C730. doi: 10.1152/ajpcell.1991.260.4.C721. [DOI] [PubMed] [Google Scholar]
  3. Bowen-Pope D. F., Ross R. Methods for studying the platelet-derived growth factor receptor. Methods Enzymol. 1985;109:69–100. doi: 10.1016/0076-6879(85)09078-4. [DOI] [PubMed] [Google Scholar]
  4. Bui K. C., Wu F., Buckley S., Wu L., Williams R., Carbonaro-Hall D., Hall F. L., Warburton D. Cyclin A expression in normal and transformed alveolar epithelial cells. Am J Respir Cell Mol Biol. 1993 Aug;9(2):115–125. doi: 10.1165/ajrcmb/9.2.115. [DOI] [PubMed] [Google Scholar]
  5. Carpenter G., Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216. doi: 10.1146/annurev.bi.48.070179.001205. [DOI] [PubMed] [Google Scholar]
  6. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 1987;56:881–914. doi: 10.1146/annurev.bi.56.070187.004313. [DOI] [PubMed] [Google Scholar]
  7. Catterton W. Z., Escobedo M. B., Sexson W. R., Gray M. E., Sundell H. W., Stahlman M. T. Effect of epidermal growth factor on lung maturation in fetal rabbits. Pediatr Res. 1979 Feb;13(2):104–108. doi: 10.1203/00006450-197902000-00004. [DOI] [PubMed] [Google Scholar]
  8. Cohen S. Epidermal growth factor. In Vitro Cell Dev Biol. 1987 Apr;23(4):239–246. doi: 10.1007/BF02623704. [DOI] [PubMed] [Google Scholar]
  9. Cool D. E., Edgell C. J., Louie G. V., Zoller M. J., Brayer G. D., MacGillivray R. T. Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa. J Biol Chem. 1985 Nov 5;260(25):13666–13676. [PubMed] [Google Scholar]
  10. Dahlbäck B., Hildebrand B., Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem. 1990 May 15;265(14):8127–8135. [PubMed] [Google Scholar]
  11. Davis R. J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993 Jul 15;268(20):14553–14556. [PubMed] [Google Scholar]
  12. Fujikawa K., McMullen B. A. Amino acid sequence of human beta-factor XIIa. J Biol Chem. 1983 Sep 25;258(18):10924–10933. [PubMed] [Google Scholar]
  13. Gasic G. P., Arenas C. P., Gasic T. B., Gasic G. J. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2317–2320. doi: 10.1073/pnas.89.6.2317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gordon E. M., Gallagher C. A., Johnson T. R., Blossey B. K., Ilan J. Hepatocytes express blood coagulation factor XII (Hageman factor). J Lab Clin Med. 1990 Apr;115(4):463–469. [PubMed] [Google Scholar]
  15. Gordon E. M., Gallagher C. A., Johnson T. R., Blossey B. K., Ilan J. Hepatocytes express blood coagulation factor XII (Hageman factor). J Lab Clin Med. 1990 Apr;115(4):463–469. [PubMed] [Google Scholar]
  16. Gordon E. M., Johnson T. R., Ramos L. P., Schmeidler-Sapiro K. T. Enhanced expression of factor XII (Hageman factor) in isolated livers of estrogen- and prolactin-treated rats. J Lab Clin Med. 1991 May;117(5):353–358. [PubMed] [Google Scholar]
  17. Huang L. H., Cheng H., Pardi A., Tam J. P., Sweeney W. V. Sequence-specific 1H NMR assignments, secondary structure, and location of the calcium binding site in the first epidermal growth factor like domain of blood coagulation factor IX. Biochemistry. 1991 Jul 30;30(30):7402–7409. doi: 10.1021/bi00244a006. [DOI] [PubMed] [Google Scholar]
  18. Kambhu S. A., Ratnoff O. D., Everson B. Inhibition of Hageman factor (factor XII) by popcorn inhibitor. J Lab Clin Med. 1985 May;105(5):625–628. [PubMed] [Google Scholar]
  19. Kraus M. H., Issing W., Miki T., Popescu N. C., Aaronson S. A. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9193–9197. doi: 10.1073/pnas.86.23.9193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Leslie C. C., McCormick-Shannon K., Robinson P. C., Mason R. J. Stimulation of DNA synthesis in cultured rat alveolar type II cells. Exp Lung Res. 1985;8(1):53–66. doi: 10.3109/01902148509069679. [DOI] [PubMed] [Google Scholar]
  21. Libby P., Ordovas J. M., Birinyi L. K., Auger K. R., Dinarello C. A. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest. 1986 Dec;78(6):1432–1438. doi: 10.1172/JCI112732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Libby P., Warner S. J., Salomon R. N., Birinyi L. K. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med. 1988 Jun 9;318(23):1493–1498. doi: 10.1056/NEJM198806093182303. [DOI] [PubMed] [Google Scholar]
  23. Lyall R. M., Zilberstein A., Gazit A., Gilon C., Levitzki A., Schlessinger J. Tyrphostins inhibit epidermal growth factor (EGF)-receptor tyrosine kinase activity in living cells and EGF-stimulated cell proliferation. J Biol Chem. 1989 Aug 25;264(24):14503–14509. [PubMed] [Google Scholar]
  24. Marshall C. J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr Opin Genet Dev. 1994 Feb;4(1):82–89. doi: 10.1016/0959-437x(94)90095-7. [DOI] [PubMed] [Google Scholar]
  25. McMullen B. A., Fujikawa K. Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor). J Biol Chem. 1985 May 10;260(9):5328–5341. [PubMed] [Google Scholar]
  26. Michalopoulos G. K. Liver regeneration: molecular mechanisms of growth control. FASEB J. 1990 Feb 1;4(2):176–187. [PubMed] [Google Scholar]
  27. Nawa K., Ono M., Fujiwara H., Sugiyama N., Uchiyama T., Marumoto Y. Monoclonal antibodies against human thrombomodulin whose epitope is located in epidermal growth factor-like domains. Biochim Biophys Acta. 1994 Apr 13;1205(2):162–170. doi: 10.1016/0167-4838(94)90229-1. [DOI] [PubMed] [Google Scholar]
  28. Persson E., Valcarce C., Stenflo J. The gamma-carboxyglutamic acid and epidermal growth factor-like domains of factor X. Effect of isolated domains on prothrombin activation and endothelial cell binding of factor X. J Biol Chem. 1991 Feb 5;266(4):2453–2458. [PubMed] [Google Scholar]
  29. Plowman G. D., Culouscou J. M., Whitney G. S., Green J. M., Carlton G. W., Foy L., Neubauer M. G., Shoyab M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1746–1750. doi: 10.1073/pnas.90.5.1746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Que B. G., Davie E. W. Characterization of a cDNA coding for human factor XII (Hageman factor). Biochemistry. 1986 Apr 8;25(7):1525–1528. doi: 10.1021/bi00355a009. [DOI] [PubMed] [Google Scholar]
  31. Ratnoff O. D., Everson B., Donaldson V. H., Mitchell B. H. Purification of Hageman factor (factor XII) on columns of popcorn-agarose. Blood. 1986 Jun;67(6):1550–1553. [PubMed] [Google Scholar]
  32. Saito H., Hamilton S. M., Tavill A. S., Goodnough L. T., Louis L., Angell A. Synthesis and release of Hageman factor (Factor XII) by the isolated perfused rat liver. J Clin Invest. 1983 Sep;72(3):948–954. doi: 10.1172/JCI111066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sanghera J. S., Paddon H. B., Bader S. A., Pelech S. L. Purification and characterization of a maturation-activated myelin basic protein kinase from sea star oocytes. J Biol Chem. 1990 Jan 5;265(1):52–57. [PubMed] [Google Scholar]
  34. Schmeidler-Sapiro K. T., Ratnoff O. D., Gordon E. M. Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4382–4385. doi: 10.1073/pnas.88.10.4382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Torres M., Hall F. L., O'Neill K. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J Immunol. 1993 Feb 15;150(4):1563–1577. [PubMed] [Google Scholar]
  36. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990 Apr 20;61(2):203–212. doi: 10.1016/0092-8674(90)90801-k. [DOI] [PubMed] [Google Scholar]
  37. Warburton D., Seth R., Shum L., Horcher P. G., Hall F. L., Werb Z., Slavkin H. C. Epigenetic role of epidermal growth factor expression and signalling in embryonic mouse lung morphogenesis. Dev Biol. 1992 Jan;149(1):123–133. doi: 10.1016/0012-1606(92)90269-m. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES